NuVasive, Inc.
https://www.nuvasive.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From NuVasive, Inc.
NuVasive Adds Artificial Cervical Disc By Acquiring Simplify For $150M
Simplify’s total disc replacement complements NuVasive’s C360 line of cervical repair surgery devices, addressing a market that could eventually be worth $2.6bn.
Orthopedic Device Firms Lobby Hard On COVID-19 Relief And Reimbursements, Among Other Issues
Firms including Depuy Synthes, Medtronic Inc., and Zimmer Biomet Holdings Inc., spent thousands of dollars lobbying Congress last winter.
Market Brief: Orthobiologics Market Will See Modest Growth By 2024, Stimulated By Growth Factors
Global sales of orthobiologics products are expected to reach $2.8bn by 2024, a CAGR of 3.2%, led by the rising aging population and musculoskeletal disease.
Medtech Giants Ready To Battle Frontrunner Intuitive Surgical In 'Soft Surgery Robotics'
The global market for robotic surgery systems is expected to reach $9.7bn by 2023. With medtech giants Medtronic, Johnson & Johnson and Zimmer Biomet launching robotic platforms in 2020, this market is set for a major shakeup.
Company Information
- Industry
- Biotechnology
-
Medical Devices
- Biomaterials
- Implantable Devices
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Biotronic NeuroNetwork
- BNN Holdings Corp
- Ellipse Technologies, Inc.
- Impulse Monitoring, Inc.
- Mega Surgical
- NuVasive®, Inc
- NuVasive Clinical Services
- NuVasive Specialized Orthopedics, Inc.
- Simplify Medical, Inc.
- Vertera Spine